Lilly’s Biotechnology Discovery Research organization is expanding its computational capabilities to build an integrated de novo design platform for therapeutic antibodies and other biotherapeutics. At the Lilly Biotechnology Center in San Diego, the platform brings together AI/ML, protein engineering, automation, structural biology, and high-throughput experimentation. It generates, ranks, and optimizes molecules for activity, safety, manufacturability, and target coverage, then uses experimental validation to continuously improve models and discovery outcomes. The program has dedicated capacity on LillyPod, a wholly owned 1,016-GPU NVIDIA Blackwell Ultra SuperPOD. The AVP of Generative Design & Optimization will define and execute the scientific strategy for turning frontier AI models into a scalable, controllable design engine for therapeutic discovery. This founding leader will establish Lilly’s long-term de novo biologics design capabilities, including how generation, conditioning, sampling, scoring, optimization, and selection produce experimentally testable candidates. The role builds and leads a high-performing organization while remaining connected to the science and ensuring innovation contributes to portfolio impact across diverse target classes.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree